"10.1371_journal.pone.0092188","plos one","2014-03-26T00:00:00Z","Tobias Größl; Elke Hammer; Sandra Bien-Möller; Anja Geisler; Sandra Pinkert; Carsten Röger; Wolfgang Poller; Jens Kurreck; Uwe Völker; Roland Vetter; Henry Fechner","Department of Applied Biochemistry, Institute of Biotechnology, Technische Universität Berlin, Berlin, Germany; Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Greifswald, Germany; Department of Pharmacology, Center of Drug Absorption and Transport, University Medicine Greifswald, Greifswald, Germany; Department of Cardiology & Pneumology, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany; Institute of Clinical Pharmacology & Toxicology, Charité - Universitätsmedizin Berlin, Campus Charité Mitte, Berlin, Germany","Conceived and designed the experiments: TG EH SBM JK RV HF. Performed the experiments: TG EH SBM SP CR AG RV. Analyzed the data: TG EH SBM RV HF. Contributed reagents/materials/analysis tools: EH SBM WP JK UV RV HF. Wrote the paper: TB JK EH RV HF.","HF and JK submitted a patent application entitled Polynucleotide sequence for the inhibition of phospholamban synthesis (Patent application number: 20100310521, Publication date: 2010-12-09). HF and WP submitted a patent application entitled RNA Interference for the Treatment of Heart Failure (Patent application number: 20110098338, Publication date: 2011-04-28). This does not alter adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors of PLOS ONE.","2014","03","Tobias Größl","TGß",11,TRUE,6,7,5,5,TRUE,TRUE,FALSE,0,NA,FALSE
